Frankfurt - Delayed Quote EUR
PTC Therapeutics, Inc. (BH3.F)
42.80
+1.40
+(3.38%)
As of 8:04:03 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALMSTEAD NEIL GREGORY Chief Technology Officer | Sale | Feb 20, 2025 | -- |
| BOULDING MARK ELLIOTT Officer | Sale | Mar 12, 2025 | 103,901 |
| GOLDEN LEE SCOTT Officer | Sale | Apr 2, 2025 | 75,997 |
| GRAVIER PIERRE Chief Financial Officer | Sale | Feb 20, 2025 | 74,436 |
| JACOBSON ALLAN STEVEN Director | Sale | Mar 4, 2025 | 19,118 |
| KLEIN MATTHEW B Chief Executive Officer | Sale | Feb 20, 2025 | 276,038 |
| OKEY STEPHANIE S Director | Sale | Mar 13, 2025 | 8,867 |
| PAUWELS ERIC Officer | Sale | Mar 17, 2025 | 72,640 |
| SMITH MARY L Director | Stock Award(Grant) | Jan 3, 2025 | 17,813 |
| UTTER CHRISTINE MARIE Officer | Sale | Feb 20, 2025 | 62,564 |
Related Tickers
4DN.F Denali Therapeutics Inc.
12.88
+13.24%
BCAX Bicara Therapeutics Inc.
15.74
+13.89%
PHVS Pharvaris N.V.
15.38
+1.92%
MBX MBX Biosciences, Inc.
9.17
+6.07%
CNTA Centessa Pharmaceuticals plc
13.09
+3.31%
SRRK Scholar Rock Holding Corporation
32.82
+3.73%
XENE Xenon Pharmaceuticals Inc.
38.20
+4.00%
MRUS Merus N.V.
42.85
-0.83%
EPIX ESSA Pharma Inc.
1.7716
-0.47%
ACRV Acrivon Therapeutics, Inc.
1.9900
-1.97%